1. The Government of Japan. National Action Plan on Antimicrobial Resistance (AMR) 2016-2020. 2016. http://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000138942.pdf. Accessed January 13th, 2022.
2. Muraki Y, Yagi T, Tsuji Y, et al. Japanese antimicrobial consumption surveillance: First report on oral and parenteral antimicrobial consumption in Japan (2009-2013). J Glob Antimicrob Resist 2016;7:19-23.
3. AMR Clinical Reference Center. Surveillance of Antimicrobial Use Based on National Database for Prescription and National Health Check-up. 2020. http://amrcrc.ncgm.go.jp/surveillance/010/20181128172333.html. Accessed January 13th, 2022.
4. Jindai K, Kusama Y, Gu Y, Honda H, Ohmagari N. Narrative Review: The Process of Expanding the Manual of Antimicrobial Stewardship by the Government of Japan. Intern Med 2021;60:181-190.
5. Fleming-Dutra KE, Hersh AL, Shapiro DJ, et al. Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011. JAMA 2016;315:1864-1873.
6. Ministry of Health, Labour and Welfare. FY 2018 Revision of Medical Fee (Japanese only). https://www.mhlw.go.jp/file/06-Seisakujouhou-12400000-Hokenkyoku/0000198532.pdf. Accessed January 13th, 2022.
7. Infectious Diseases Control Division, Health Service Bureau, Ministry of Health, Labour and Welfare. Manual of Antimicrobial Stewardship (1st Edition). 2017. https://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000193504.pdf. Accessed January 13, 2022.
8. Balinskaite V, Johnson AP, Holmes A, Aylin P. The Impact of a National Antimicrobial Stewardship Program on Antibiotic Prescribing in Primary Care: An Interrupted Time Series Analysis. Clin Infect Dis 2019;69:227-232.
9. Ellegård LM, Dietrichson J, Anell A. Can pay-for-performance to primary care providers stimulate appropriate use of antibiotics? Health Econ 2018;27:e39-e54.
10. JMDC Inc. The JMDC Claims Database. https://www.jmdc.co.jp/en/jmdc-claims-database. Accessed January 3rd, 2022.
11. Nagai K, Tanaka T, Kodaira N, Kimura S, Takahashi Y, Nakayama T. Data resource profile: JMDC claims databases sourced from Medical Institutions. J Gen Fam Med 2020;21:211-218.
12. Kimura Y, Fukuda H, Hayakawa K, et al. Longitudinal trends of and factors associated with inappropriate antibiotic prescribing for non-bacterial acute respiratory tract infection in Japan: A retrospective claims database study, 2012-2017. PLoS One 2019;14:e0223835.
13. Sato D, Goto T, Uda K, Kumazawa R, Matsui H, Yasunaga H. Impact of national guidelines for antimicrobial stewardship to reduce antibiotic use in upper respiratory tract infection and gastroenteritis. Infect Control Hosp Epidemiol 2020:1-7.
14. Anatomical Therapeutic Chemical (ATC) Classification. https://www.who.int/tools/atc-ddd-toolkit/atc-classification. Accessed March 20th, 2021.
15. Shadish WR, Cook TD, Campbell DT. Experimental and quasi-experimental designs for generalized causal inference. Boston, MA, US: Houghton, Mifflin and Company; 2002.
16. Saito H, Noda H, Takakura S, Jindai K, Takahashi McLellan R, Asanuma K. First Major Practical Step toward Appropriate Antimicrobial Use by the Government of Japan. Jpn J Infect Dis 2019;72:56-57.
17. Infectious Diseases Control Division, Health Service Bureau, Ministry of Health, Labour and Welfare. Manual of Antimicrobial Stewardship (1st Edition). Digest Version. Japanese only. 2017. https://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/tebiki_1.pdf. Accessed October 31st, 2020.
18. Gillings D, Makuc D, Siegel E. Analysis of interrupted time series mortality trends: an example to evaluate regionalized perinatal care. Am J Public Health 1981;71:38-46.
19. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002;27:299-309.
20. BigQuery: Cloud Data Warehouse | Google Cloud. https://cloud.google.com/bigquery. Accessed January 13th, 2022.
21. Wise J. Hospitals and GPs are offered incentives to reduce antibiotic prescribing. BMJ 2016;352:i1499.
22. Bou-Antoun S, Costelloe C, Honeyford K, et al. Age-related decline in antibiotic prescribing for uncomplicated respiratory tract infections in primary care in England following the introduction of a national financial incentive (the Quality Premium) for health commissioners to reduce use of antibiotics in the community: an interrupted time series analysis. J Antimicrob Chemother 2018;73:2883-2892.
23. Jindai K, Goto M, MacKay K, et al. Improving fluoroquinolone use in the outpatient setting using a patient safety initiative. Infect Control Hosp Epidemiol 2018;39:1108-1111.
24. Persell SD, Doctor JN, Friedberg MW, et al. Behavioral interventions to reduce inappropriate antibiotic prescribing: a randomized pilot trial. BMC infectious diseases 2016;16:373.
25. Ministry of Health, Labour and Welfare. FY 2020 Revision of Medical Fee (Japanese only). https://www.mhlw.go.jp/content/12400000/000605493.pdf. Accessed January 13th, 2022.
26. Infectious Diseases Control Division, Health Service Bureau, Ministry of Health, Labour and Welfare. Manual of Antimicrobial Stewardship (2nd Edition) (Japanese only). 2019. https://www.mhlw.go.jp/content/10900000/000573655.pdf. Accessed March 20th, 2021.
27. Gerber JS, Prasad PA, Fiks AG, et al. Effect of an outpatient antimicrobial stewardship intervention on broad-spectrum antibiotic prescribing by primary care pediatricians: a randomized trial. JAMA 2013;309:2345-2352.
28. Gerber JS, Prasad PA, Fiks AG, et al. Durability of Benefits of an Outpatient Antimicrobial Stewardship Intervention After Discontinuation of Audit and Feedback. JAMA 2014;312:2569-2570.
29. Yamamoto S, Gu Y, Fujitomo Y, et al. Development and efficacy of a clinician- targeted refresher course for treating nonpneumonia respiratory tract infections. J Gen Fam Med 2018;19:127-132.
30. Muraki Y, Kusama Y, Tanabe M, et al. Impact of antimicrobial stewardship fee on prescribing for Japanese pediatric patients with upper respiratory infections. BMC Health Serv Res 2020;20:399-399.
31. Hashimoto H, Saito M, Sato J, et al. Indications and classes of outpatient antibiotic prescriptions in Japan: A descriptive study using the national database of electronic health insurance claims, 2012-2015. Int J Infect Dis 2019;91:1-8.
32. van Walraven C, Bennett C, Forster AJ. Administrative database research infrequently used validated diagnostic or procedural codes. J Clin Epidemiol 2011;64:1054- 1059.
33. Yamana H, Moriwaki M, Horiguchi H, Kodan M, Fushimi K, Yasunaga H. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol 2017;27:476-482.
34. Koram N, Delgado M, Stark JH, Setoguchi S, de Luise C. Validation studies of claims data in the Asia-Pacific region: A comprehensive review. Pharmacoepidemiol Drug Saf 2019;28:156-170.
35. Horsky J, Drucker EA, Ramelson HZ. Accuracy and Completeness of Clinical Coding Using ICD-10 for Ambulatory Visits. AMIA Annu Symp Proc 2018;2017:912-920.
36. Kontopantelis E, Doran T, Springate DA, Buchan I, Reeves D. Regression based quasi-experimental approach when randomisation is not an option: interrupted time series analysis. BMJ 2015;350:h2750.
37. Hicks LA, Bartoces MG, Roberts RM, et al. US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011. Clin Infect Dis 2015;60:1308-1316.
38. Uda K, Kinoshita N, Morisaki N, Kasai M, Horikoshi Y, Miyairi I. Targets for Optimizing Oral Antibiotic Prescriptions for Pediatric Outpatients in Japan. JJID 2019;72:149-159.
39. Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol 2016;46:348-355.